Press release
Wet Age-Related Macular Degeneration Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharma, Ltd., K
To Know in detail about the Wet Age-Related Macular Degeneration market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Wet Age-Related Macular Degeneration Market Forecast
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Wet Age-Related Macular Degeneration Market Report:
• The Wet Age-Related Macular Degeneration market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In December 2023, EyePoint Pharmaceuticals, a pharmaceutical firm headquartered in the United States, has unveiled encouraging top-line findings from the Phase II DAVIO 2 clinical study involving its sustained-release maintenance treatment, EYP-1901. EYP-1901, currently under investigation, holds promise as a potential therapy for addressing wet age-related macular degeneration (wet AMD).
• In the 7MM, there will likely be 51,743,361 instances of age-related macular degeneration overall in 2021. By 2032, these cases are projected to rise due to a number of risk factors, including ageing, improved care, and increased awareness
• In 2021, the United States had the highest prevalence of Age-Related Macular Degeneration cases among the 7MM, with about 17,282,569 cases
• A total of 38,807,521 diagnosed prevalent instances of age-related macular degeneration were discovered to exist in the 7MM in 2021. By 2032, there should be an increase in these cases
• With 588,809 diagnosed cases, Germany had the highest prevalence of wet age-related macular degeneration among the European nations in 2021, followed by France with 372,836 cases. However, Spain had the lowest diagnosed prevalence rate in 2021
• Wet age-related macular degeneration has a dynamic pipeline. Opthea Limited (OPT-302), Alkahest, Inc. (AKST4290), Graybug Vision (Sunitinib Malate), Ribomic USA (RBM-007), Regenxbio (RGX-314), and Outlook Therapeutics (ONS-5010) are important participants. Throughout the anticipated era (2023-2032), these medications are anticipated to hit the market
• Key Wet Age-Related Macular Degeneration Companies: Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharmaceutical Co., Ltd., Kodiak Sciences Inc, EyePoint Pharmaceuticals, Inc., Laboratorio Elea Phoenix S.A., Sam Chun Dang Pharma, RemeGen Co., Ltd., Ophthotech Corporation, Mabwell, Novartis, Hoffmann-La Roche, Boehringer Ingelheim, Cinnagen, and others
• Key Wet Age-Related Macular Degeneration Therapies: OPT-302, RGX-314, AKST4290, GB-102, Anecortave Acetate 15 mg, Aflibercept, KSI-301, Eyp-1901, ALK4290, Bevacizumab (Lumiere®), SCD411, RC28-E, Zimura, MW02, ranibizumab, Faricimab, BI 144807, Aflibercept, and others
• The Wet Age-Related Macular Degeneration epidemiology based on gender analyzed that prevalence of Dry Age-Related Macular Degeneration is higher than Wet Age-Related Macular Degeneration
• The Wet Age-Related Macular Degeneration market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Wet Age-Related Macular Degeneration pipeline products will significantly revolutionize the Wet Age-Related Macular Degeneration market dynamics.
Wet Age-Related Macular Degeneration Overview
Wet Age-Related Macular Degeneration (Wet AMD) is a chronic eye condition that affects the macula, the central part of the retina responsible for sharp, central vision. It is a progressive disease that can lead to significant vision loss if left untreated.
Get a Free sample for the Wet Age-Related Macular Degeneration Market Report:
https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Wet Age-Related Macular Degeneration Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Wet Age-Related Macular Degeneration Epidemiology Segmentation:
The Wet Age-Related Macular Degeneration market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Wet Age-Related Macular Degeneration
• Prevalent Cases of Wet Age-Related Macular Degeneration by severity
• Gender-specific Prevalence of Wet Age-Related Macular Degeneration
• Diagnosed Cases of Episodic and Chronic Wet Age-Related Macular Degeneration
Download the report to understand which factors are driving Wet Age-Related Macular Degeneration epidemiology trends @ Wet Age-Related Macular Degeneration Epidemiology Forecast
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Wet Age-Related Macular Degeneration Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Wet Age-Related Macular Degeneration market or expected to get launched during the study period. The analysis covers Wet Age-Related Macular Degeneration market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Wet Age-Related Macular Degeneration Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Wet Age-Related Macular Degeneration Therapies and Key Companies
• OPT-302: Opthea Limited
• RGX-314: Regenxbio
• AKST4290: Alkahest
• GB-102: Graybug Vision
• Anecortave Acetate 15 mg: Alcon Research
• Aflibercept: Qilu Pharmaceutical Co., Ltd.
• KSI-301: Kodiak Sciences Inc
• Eyp-1901: EyePoint Pharmaceuticals, Inc.
• ALK4290: Alkahest, Inc.
• Bevacizumab (Lumiere®): Laboratorio Elea Phoenix S.A.
• SCD411: Sam Chun Dang Pharma
• RC28-E: RemeGen Co., Ltd.
• Zimura: Ophthotech Corporation
• MW02: Mabwell
• ranibizumab: Novartis
• Faricimab: Hoffmann-La Roche
• BI 144807: Boehringer Ingelheim
• Aflibercept: Cinnagen
Discover more about therapies set to grab major Wet Age-Related Macular Degeneration market share @ Wet Age-Related Macular Degeneration Treatment Market
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Wet Age-Related Macular Degeneration Market Drivers
• Increasing prevalence of wet AMD
• Development in the field of gene therapy
• Robust pipeline
• Novel oral formulations for the treatment of wet AMD
Wet Age-Related Macular Degeneration Market Barriers
• High cost of treatment
• Competitive treatment landscape
• Emerging biosimilars
• Low compliance
Scope of the Wet Age-Related Macular Degeneration Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Wet Age-Related Macular Degeneration Companies: Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharmaceutical Co., Ltd., Kodiak Sciences Inc, EyePoint Pharmaceuticals, Inc., Laboratorio Elea Phoenix S.A., Sam Chun Dang Pharma, RemeGen Co., Ltd., Ophthotech Corporation, Mabwell, Novartis, Hoffmann-La Roche, Boehringer Ingelheim, Cinnagen, and others
• Key Wet Age-Related Macular Degeneration Therapies: OPT-302, RGX-314, AKST4290, GB-102, Anecortave Acetate 15 mg, Aflibercept, KSI-301, Eyp-1901, ALK4290, Bevacizumab (Lumiere®), SCD411, RC28-E, Zimura, MW02, ranibizumab, Faricimab, BI 144807, Aflibercept, and others
• Wet Age-Related Macular Degeneration Therapeutic Assessment: Wet Age-Related Macular Degeneration current marketed and Wet Age-Related Macular Degeneration emerging therapies
• Wet Age-Related Macular Degeneration Market Dynamics: Wet Age-Related Macular Degeneration market drivers and Wet Age-Related Macular Degeneration market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Wet Age-Related Macular Degeneration Unmet Needs, KOL's views, Analyst's views, Wet Age-Related Macular Degeneration Market Access and Reimbursement
To know more about Wet Age-Related Macular Degeneration companies working in the treatment market, visit @ Wet Age-Related Macular Degeneration Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/wet-age-related-macular-degeneration-wet-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Wet Age-Related Macular Degeneration Market Report Introduction
2. Executive Summary for Wet Age-Related Macular Degeneration
3. SWOT analysis of Wet Age-Related Macular Degeneration
4. Wet Age-Related Macular Degeneration Patient Share (%) Overview at a Glance
5. Wet Age-Related Macular Degeneration Market Overview at a Glance
6. Wet Age-Related Macular Degeneration Disease Background and Overview
7. Wet Age-Related Macular Degeneration Epidemiology and Patient Population
8. Country-Specific Patient Population of Wet Age-Related Macular Degeneration
9. Wet Age-Related Macular Degeneration Current Treatment and Medical Practices
10. Wet Age-Related Macular Degeneration Unmet Needs
11. Wet Age-Related Macular Degeneration Emerging Therapies
12. Wet Age-Related Macular Degeneration Market Outlook
13. Country-Wise Wet Age-Related Macular Degeneration Market Analysis (2019-2032)
14. Wet Age-Related Macular Degeneration Market Access and Reimbursement of Therapies
15. Wet Age-Related Macular Degeneration Market Drivers
16. Wet Age-Related Macular Degeneration Market Barriers
17. Wet Age-Related Macular Degeneration Appendix
18. Wet Age-Related Macular Degeneration Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Latest Reports by DelveInsight
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wet Age-Related Macular Degeneration Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu Pharma, Ltd., K here
News-ID: 3489535 • Views: …
More Releases from DelveInsight Business Research
Ataxia Telangiectasia Market Dynamics Indicate Upward Trajectory Through 2034, R …
DelveInsight's "Ataxia Telangiectasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Ataxia Telangiectasia, historical and forecasted epidemiology as well as the Ataxia Telangiectasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Ataxia Telangiectasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ataxia Telangiectasia Market Forecast
https://www.delveinsight.com/sample-request/ataxia-telangiectasia-at-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Primary Biliary Cholangitis Market Expected to Gain Momentum Through 2034, Accor …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis…
Hypertrophic Cardiomyopathy Market to Show Remarkable Growth Trends from 2024 to …
DelveInsight's "Hypertrophic Cardiomyopathy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Hypertrophic Cardiomyopathy, historical and forecasted epidemiology as well as the Hypertrophic Cardiomyopathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hypertrophic Cardiomyopathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hypertrophic Cardiomyopathy Market Forecast
https://www.delveinsight.com/sample-request/hypertrophic-cardiomyopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Kidney Transplant Rejection Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Kidney Transplant Rejection Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Kidney Transplant Rejection, historical and forecasted epidemiology as well as the Kidney Transplant Rejection market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Kidney Transplant Rejection market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Kidney Transplant Rejection…
More Releases for Wet
Wet Age-Related Macular Degeneration (Wet AMD) market is expected to reach USD 1 …
Wet age-related macular degeneration (Wet AMD) is a chronic, progressive eye disorder and one of the leading causes of severe vision loss in people over 60. Unlike the dry form of AMD, Wet AMD is characterized by the growth of abnormal blood vessels under the retina that leak fluid or blood, leading to rapid central vision loss. While Wet AMD accounts for only about 10-15% of all AMD cases, it…
Wet And Cold Appliance Market Size Analysis by Application, Type, and Region: Fo …
USA, New Jersey- According to Market Research Intellect, the global Wet And Cold Appliance market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The wet and cold appliance market is expanding steadily, driven by changing consumer lifestyles, increasing urbanization, and rising demand for home automation. Appliances…
Semiconductor Electronic Wet Chemicals Market
Semiconductor Electronic Wet Chemicals Market Overview
Electronic wet chemicals are ultra-pure nature due to which they are extensively used in cleaning and etching application during semiconductor production and processing.
This report provides a deep insight into the global Semiconductor Electronic Wet Chemicals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market…
Wet and Dry Vacuum Cleaner Market
The "Wet and Dry Vacuum Cleaner Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Wet and Dry Vacuum Cleaner Market, 2024-2031
Verified Market Research's most recent report, "Wet and Dry Vacuum Cleaner Market: Global Industry Trends, Share, Size,…
Wet Filtered Downdraught Workbench Market
Wet filtered downdraught workbench is the industry's leading solution for the collection of combustible metal dust which can safely removes combustible materials while complying with NFPA and OSHA combustible dust guidelines.
The global Wet Filtered Downdraught Workbench market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine…
Corn Wet-milling Market Corn Wet Milling Market Share, Size, Demand, Key Players …
Market Analysis and Insights of Global Corn Wet-milling Market
The corn wet-milling market is expected to witness market growth at a rate of 5.70% in the forecast period of 2022 to 2029. Data Bridge Market Research report on corn wet-milling market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The growth in awareness globally is…
